Filter
1162
Text search:
drug
resistance
management
program
Featured
126
384
Language
Document type
700
168
156
54
41
25
7
7
2
1
1
Countries / Regions
68
47
47
34
33
30
30
30
27
26
25
24
23
22
21
20
19
17
16
14
13
13
12
11
10
9
8
8
7
7
7
7
6
6
6
6
5
5
5
5
4
4
4
4
4
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
561
73
54
29
27
16
15
Toolboxes
179
127
107
52
37
31
31
21
21
17
17
12
10
9
9
7
6
6
4
4
4
3
3
1
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
Key populations brief.
Draft for consultation
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines
This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential Medicines (EML) and the Model List of Essential Medicine for Children (EMLc)
...
An Evidence-Based Treatment Guide for Clinicians
In 2020, the COVID-19 pandemic impacted the world beyond imagination. To date, it has infected more than 135 million people, killed over 2.9 million people, and is projected to plunge up to 115 million people into extreme poverty.1 As countries have gone into lockdown, gender-based violence has incr
...
Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline
recommended
This second edition of the Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline provides the most up to date technical guidance on mask use in community settings in the context of COVID-19.
In this edition, new information includes updated mask re
...
Government of Nepal has an obligation to ensure availability of affordable and high quality basic health care services to its population
